Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8789406 | Revista Colombiana de Cancerología | 2018 | 4 Pages |
Abstract
Cancer-associated thrombotic microangiopathy (CATM) consists of microangiopathic haemolytic anaemia, thrombocytopenia, and ischaemic end organ-damage in patients with a known or unknown primary malignancy. Its diagnosis is challenging, as it is sometimes confused with thrombotic thrombocytopenic purpura, which is the most common cause of thrombotic microangiopathy in healthy patients. CATM can be a manifestation of the malignancy itself or a chemotherapy-related complication, with these patients having a poor prognosis. A case is presented of a patient who developed CATM in the context of metastatic cancer with an unknown primary site.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Alejandra Castillo Ramirez, José Burillo Lorente, Pablo Javier Marchena Yglesias,